357 related articles for article (PubMed ID: 10910057)
1. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol.
Bennett LM; McAllister KA; Malphurs J; Ward T; Collins NK; Seely JC; Gowen LC; Koller BH; Davis BJ; Wiseman RW
Cancer Res; 2000 Jul; 60(13):3461-9. PubMed ID: 10910057
[TBL] [Abstract][Full Text] [Related]
2. Pathological changes in female C3H mice continuously fed diets containing diethylstilbestrol or 17beta--estradiol.
Highman B; Norvell MJ; Shellenberger TE
J Environ Pathol Toxicol; 1978; 1(1):1-30. PubMed ID: 722180
[TBL] [Abstract][Full Text] [Related]
3. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.
Rajan JV; Marquis ST; Gardner HP; Chodosh LA
Dev Biol; 1997 Apr; 184(2):385-401. PubMed ID: 9133444
[TBL] [Abstract][Full Text] [Related]
4. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-alpha transgene expression.
Gray K; Bullock B; Dickson R; Raszmann K; Walmer D; McLachlan J; Merlino G
Mol Carcinog; 1996 Nov; 17(3):163-73. PubMed ID: 8944077
[TBL] [Abstract][Full Text] [Related]
6. Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice.
Blackshear PE; Goldsworthy SM; Foley JF; McAllister KA; Bennett LM; Collins NK; Bunch DO; Brown P; Wiseman RW; Davis BJ
Oncogene; 1998 Jan; 16(1):61-8. PubMed ID: 9467943
[TBL] [Abstract][Full Text] [Related]
7. Effects of a low oral dose of diethylstilbestrol (DES) on reproductive tract development in F1 female CD-1 mice.
Maranghi F; Tassinari R; Moracci G; Macrì C; Mantovani A
Reprod Toxicol; 2008 Oct; 26(2):146-50. PubMed ID: 18692564
[TBL] [Abstract][Full Text] [Related]
8. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
9. Morphological effects of diethylstilbestrol on neonatal mouse uterus and vagina.
Plapinger L
Cancer Res; 1981 Nov; 41(11 Pt 1):4667-77. PubMed ID: 7306983
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of DES carcinogenicity: effects of the TGF alpha transgene.
Gray K; Bullock B; Dickson R; Raszmann K; McLachlan J; Merlino G
Prog Clin Biol Res; 1997; 396():217-31. PubMed ID: 9108600
[TBL] [Abstract][Full Text] [Related]
11. Influence of age on induction of mammary tumors by diethylstilbestrol in C3H/HeN mice with low murine mammary tumor virus titer.
Greenman DL; Highman B; Chen JJ; Schieferstein GJ; Norvell MJ
J Natl Cancer Inst; 1986 Oct; 77(4):891-8. PubMed ID: 3020299
[TBL] [Abstract][Full Text] [Related]
12. Developmental effects of ethinylestradiol on reproductive organs of female mice.
Kirigaya A; Hayashi S; Iguchi T; Sato T
In Vivo; 2006; 20(6B):867-73. PubMed ID: 17203781
[TBL] [Abstract][Full Text] [Related]
13. MMTV-trBrca1 mice display strain-dependent abnormalities in vaginal development.
Simpson KJ; Wati MR; Deans AJ; Lindeman GJ; Brown MA
Int J Dev Biol; 2004 Sep; 48(7):675-8. PubMed ID: 15470641
[TBL] [Abstract][Full Text] [Related]
14. Long-term alterations in histology and steroid receptor levels of the genital tract and mammary gland following neonatal exposure of female BALB/cCrgl mice to various doses of diethylstilbestrol.
Bern HA; Edery M; Mills KT; Kohrman AF; Mori T; Larson L
Cancer Res; 1987 Aug; 47(15):4165-72. PubMed ID: 3607758
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from BRCA1 and BRCA2.
Zheng L; Li S; Boyer TG; Lee WH
Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
Rebbeck TR
J Clin Oncol; 2000 Nov; 18(21 Suppl):100S-3S. PubMed ID: 11060335
[TBL] [Abstract][Full Text] [Related]
17. Strain differences in the response of the mouse to diethylstilbestrol.
Greenman DL; Dooley K; Breeden CR
J Toxicol Environ Health; 1977 Oct; 3(3):589-97. PubMed ID: 926210
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of neonatal treatment with progesterone, alone and in combination with estrogen, on the mammary gland and reproductive tract of female BALB/cfC3H mice.
Jones LA; Bern HA
Cancer Res; 1977 Jan; 37(1):67-75. PubMed ID: 830422
[TBL] [Abstract][Full Text] [Related]
20. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A
Cancer Res; 2005 Oct; 65(19):8736-46. PubMed ID: 16204043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
